Search research articles
Contact Us
Filters
Showing results (251-260 of 278) with videos related to
Page
of 28
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 3, 2024
Correction: Phase I/Ib Clinical Trial of Sabatolimab, an Anti-TIM-3 Antibody, Alone and in Combination with Spartalizumab, an Anti-PD-1 Antibody, in Advanced Solid Tumors
Giuseppe Curigliano, Hans Curigliano, Nicolas Mach, et al.
NPJ Precision Oncology
|
February 11, 2026
Innate lymphoid cell heterogeneity and etiology-specific reprogramming in hepatocellular carcinoma
Yun Hua Lee, Samuel Chuah, Wei Qiang Leow, et al.
Liver Cancer
|
September 26, 2022
Systemic Treatment of Advanced Unresectable Hepatocellular Carcinoma after First-Line Therapy: Expert Recommendations from Hong Kong, Singapore, and Taiwan
Thomas Yau, David Tai, Stephen Lam Chan, et al.
The Lancet. Oncology
|
August 14, 2019
Rogaratinib in patients with advanced cancers selected by FGFR mRNA expression: a phase 1 dose-escalation and dose-expansion study
Martin Schuler, Byoung Chul Cho, Cyrus Michael Sayehli, et al.
Nature Medicine
|
February 20, 2024
Regorafenib plus nivolumab in unresectable hepatocellular carcinoma: the phase 2 RENOBATE trial
Hyung-Don Kim, Seyoung Jung, Ho Yeong Lim, et al.
Plos Computational Biology
|
February 18, 2025
Tumor-immune partitioning and clustering algorithm for identifying tumor-immune cell spatial interaction signatures within the tumor microenvironment
Mai Chan Lau, Jennifer Borowsky, Juha P Väyrynen, et al.
Journal of Gastrointestinal Oncology
|
November 12, 2025
Effects of current smoking on treatment outcomes in metastatic and locally advanced pancreatic carcinoma: a retrospective cohort study using the international PURPLE pancreas cancer registry
Faisal Hayat, Simon Chiu, Ashleigh Stuart, et al.
Nature Nanotechnology
|
August 6, 2021
Intrinsic bioactivity of black phosphorus nanomaterials on mitotic centrosome destabilization through suppression of PLK1 kinase
Ximing Shao, Zhihao Ding, Wenhua Zhou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 4, 2021
Results from a First-in-Human Phase I Study of Siremadlin (HDM201) in Patients with Advanced Wild-Type TP53 Solid Tumors and Acute Leukemia
Eytan M Stein, Daniel J DeAngelo, Jörg Chromik, et al.
Frontiers in Immunology
|
June 21, 2023
Immunohistochemical scoring of LAG-3 in conjunction with CD8 in the tumor microenvironment predicts response to immunotherapy in hepatocellular carcinoma
Chun Chau Lawrence Cheung, Yong Hock Justin Seah, Juntao Fang, et al.
Page
of 28
Search research articles
Search
Showing results (251-260 of 278) with videos related to
Sort By:
Page
of 28
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 3, 2024
Correction: Phase I/Ib Clinical Trial of Sabatolimab, an Anti-TIM-3 Antibody, Alone and in Combination with Spartalizumab, an Anti-PD-1 Antibody, in Advanced Solid Tumors
Giuseppe Curigliano, Hans Curigliano, Nicolas Mach, et al.
NPJ Precision Oncology
|
February 11, 2026
Innate lymphoid cell heterogeneity and etiology-specific reprogramming in hepatocellular carcinoma
Yun Hua Lee, Samuel Chuah, Wei Qiang Leow, et al.
Liver Cancer
|
September 26, 2022
Systemic Treatment of Advanced Unresectable Hepatocellular Carcinoma after First-Line Therapy: Expert Recommendations from Hong Kong, Singapore, and Taiwan
Thomas Yau, David Tai, Stephen Lam Chan, et al.
The Lancet. Oncology
|
August 14, 2019
Rogaratinib in patients with advanced cancers selected by FGFR mRNA expression: a phase 1 dose-escalation and dose-expansion study
Martin Schuler, Byoung Chul Cho, Cyrus Michael Sayehli, et al.
Nature Medicine
|
February 20, 2024
Regorafenib plus nivolumab in unresectable hepatocellular carcinoma: the phase 2 RENOBATE trial
Hyung-Don Kim, Seyoung Jung, Ho Yeong Lim, et al.
Plos Computational Biology
|
February 18, 2025
Tumor-immune partitioning and clustering algorithm for identifying tumor-immune cell spatial interaction signatures within the tumor microenvironment
Mai Chan Lau, Jennifer Borowsky, Juha P Väyrynen, et al.
Journal of Gastrointestinal Oncology
|
November 12, 2025
Effects of current smoking on treatment outcomes in metastatic and locally advanced pancreatic carcinoma: a retrospective cohort study using the international PURPLE pancreas cancer registry
Faisal Hayat, Simon Chiu, Ashleigh Stuart, et al.
Nature Nanotechnology
|
August 6, 2021
Intrinsic bioactivity of black phosphorus nanomaterials on mitotic centrosome destabilization through suppression of PLK1 kinase
Ximing Shao, Zhihao Ding, Wenhua Zhou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 4, 2021
Results from a First-in-Human Phase I Study of Siremadlin (HDM201) in Patients with Advanced Wild-Type TP53 Solid Tumors and Acute Leukemia
Eytan M Stein, Daniel J DeAngelo, Jörg Chromik, et al.
Frontiers in Immunology
|
June 21, 2023
Immunohistochemical scoring of LAG-3 in conjunction with CD8 in the tumor microenvironment predicts response to immunotherapy in hepatocellular carcinoma
Chun Chau Lawrence Cheung, Yong Hock Justin Seah, Juntao Fang, et al.
Page
of 28